Grey market for unlicensed peptides grows in Ireland amid safety concerns

Peptides are increasingly sold on Ireland's grey market, marketed as not for human consumption to bypass medicine licensing. Safety oversight is absent, raising public-health risks. The scale of use and regulatory response remain uncertain.